摘要
目的探讨行经皮冠状动脉介入术(PCI)的ST段抬高型心肌梗死患者采用替格瑞洛与氯吡格雷治疗的临床效果。方法按照随机数字表法,将78例接受PCI治疗的ST段抬高型心肌梗死患者分为研究组(替格瑞洛)与对照组(氯吡格雷)。结果两组心功能指标对比,差异有统计学意义(P<0.05);研究组、对照组心血管事件发生率分别为7.7%、25.6%(P<0.05)。结论 ST段抬高型心肌梗死患者在PCI治疗过程中,辅以替格瑞洛的效果显著。
Objective Study of percutaneous coronary intervention （PCI） clinical effect of ticagrelor versus clopidogrel therapy used in patients with ST elevation myocardial infarction. Methods According to the random number table method, 78 patients with ST segment elevation myocardial infarction （PCI） were divided into study group （Grillo） and control group （clopidogrel）. Results There were significant differences in cardiac function indexes between the two groups （P〈0.05）. The incidence of cardiovascular events in the study group and the control group were 7.7% and 25.6% （P〈0.05） respectively. Conclusion ST segment elevation myocardial infarction patients in the treatment of PC1, supplemented by Grillo effect is significant.
作者
孙克彬
SUN Kebin(Internal Medicine-Cardiovascular Department, Dunhua Municipal Hospital, Dunhua Jilin 133700, China)
出处
《中国继续医学教育》
2017年第4期181-183,共3页
China Continuing Medical Education
